Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Eddy (London, Canada). Ventilation heterogeneity reversibility: asthma, COPD or ACOS?. 4646

Member's Comments

No comment yet.

Related content which might interest you: Airflow reversibility on long term outcomes of patients with COPD Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014 Airway resistances deteriorate following spirometry in asthma and COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Bronchodilator reversibility - differences between asthma and COPD Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019 What is COPD? What is asthma? Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 Lung function change and exacerbations in patients with COPD in the WISDOM study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Breathlessness perception in COPD: Relationship with exacerbation frequency Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015 A pilot study of CPAP therapy for excessive dynamic airway collapse during acute exacerbation of COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Frequency of COPD exacerbations and severity of COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Body-plethysmographic measurements of bronchodilator response in stable COPD Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014 Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Impulse-oscillometry (IOS) differences in asthma and COPD patients, and healthy-subjects Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014 Can emphysema predict exacerbations and changes in PFTs in COPD? Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Poor perception of bronchoconstriction and hyperinflation and risk of acute asthma exaerbations: A data linkage analysis Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Bronchodilator reversibility testing in COPD: which parameter? Source: Eur Respir J 2006; 28: Suppl. 50, 202s Year: 2006 Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Do all COPD patients present irreversible airflow limitation? Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013